|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
220 a.a.
|
 |
|
|
|
|
|
|
|
212 a.a.
|
 |
|
|
|
|
|
|
|
16 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Viral protein/immune system
|
 |
|
Title:
|
 |
Fab fragment (antibody 8f5) complexed with peptide from human rhinovirus (serotype 2) viral capsid protein vp2 (residues 156-170)
|
|
Structure:
|
 |
Igg2a 8f5 fab (light chain). Chain: l. Fragment: fab fragment (papain digestion). Synonym: antibody 8f5. Igg2a 8f5 fab (heavy chain). Chain: h. Fragment: fab fragment (papain digestion). Synonym: antibody 8f5. Human rhinovirus capsid protein vp2.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Human rhinovirus 2. Organism_taxid: 12130. Strain: serotype 2. Other_details: common cold virus
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
|
Authors:
|
 |
J.Tormo,D.Blaas,I.Fita
|
|
Key ref:
|
 |
J.Tormo
et al.
(1994).
Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2.
Embo J,
13,
2247-2256.
PubMed id:
|
 |
|
Date:
|
 |
|
23-Jan-98
|
Release date:
|
29-Apr-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q52L64
(Q52L64_MOUSE) -
ENSMUSG00000076577 protein from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
240 a.a.
220 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain P:
E.C.2.7.7.48
- RNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
RNA(n)
|
+
|
ribonucleoside 5'-triphosphate
|
=
|
RNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain P:
E.C.3.4.22.28
- picornain 3C.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chain P:
E.C.3.4.22.29
- picornain 2A.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
|
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chain P:
E.C.3.6.1.15
- nucleoside-triphosphate phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
|
 |
 |
 |
 |
 |
ribonucleoside 5'-triphosphate
|
+
|
H2O
|
=
|
ribonucleoside 5'-diphosphate
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Embo J
13:2247-2256
(1994)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2.
|
|
J.Tormo,
D.Blaas,
N.R.Parry,
D.Rowlands,
D.Stuart,
I.Fita.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The three-dimensional structure of the complex between the Fab fragment of an
anti-human rhinovirus neutralizing antibody (8F5) and a cross-reactive synthetic
peptide from the viral capsid protein VP2 has been determined at 2.5 A
resolution by crystallographic methods. The refinement is presently at an R
factor of 0.18 and the antigen-binding site and viral peptide are well defined.
The peptide antigen adopts a compact fold by two tight turns and interacts
through hydrogen bonds, some with ionic character, and van der Waals contacts
with antibody residues from the six hypervariable loops as well as several
framework amino acids. The conformation adopted by the peptide is closely
related to the corresponding region of the viral protein VP2 on the surface of
human rhinovirus 1A whose three-dimensional structure is known. Implications for
the cross-reactivity between peptides and the viral capsid are discussed. The
peptide-antibody interactions, together with the analysis of mutant viruses that
escape neutralization by 8F5 suggest two different mechanisms for viral escape.
The comparison between the complexed and uncomplexed antibody structures shows
important conformational rearrangements, especially in the hypervariable loops
of the heavy chain. Thus, it constitutes a clear example of the 'induced fit'
molecular recognition mechanism.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
U.Katpally,
T.M.Fu,
D.C.Freed,
D.R.Casimiro,
and
T.J.Smith
(2009).
Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization.
|
| |
J Virol,
83,
7040-7048.
|
 |
|
|
|
|
 |
F.E.Tynan,
S.R.Burrows,
A.M.Buckle,
C.S.Clements,
N.A.Borg,
J.J.Miles,
T.Beddoe,
J.C.Whisstock,
M.C.Wilce,
S.L.Silins,
J.M.Burrows,
L.Kjer-Nielsen,
L.Kostenko,
A.W.Purcell,
J.McCluskey,
and
J.Rossjohn
(2005).
T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.
|
| |
Nat Immunol,
6,
1114-1122.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.J.Cachia,
D.J.Kao,
and
R.S.Hodges
(2004).
Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy.
|
| |
J Mol Recognit,
17,
540-557.
|
 |
|
|
|
|
 |
F.E.Romesberg
(2003).
Multidisciplinary experimental approaches to characterizing biomolecular dynamics.
|
| |
Chembiochem,
4,
563-571.
|
 |
|
|
|
|
 |
J.Kolberg,
A.Aase,
G.Rødal,
J.E.Littlejohn,
and
M.J.Jedrzejas
(2003).
Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modelling.
|
| |
FEMS Immunol Med Microbiol,
39,
265-273.
|
 |
|
|
|
|
 |
P.J.Cachia,
and
R.S.Hodges
(2003).
Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
|
| |
Biopolymers,
71,
141-168.
|
 |
|
|
|
|
 |
C.Hunte,
and
H.Michel
(2002).
Crystallisation of membrane proteins mediated by antibody fragments.
|
| |
Curr Opin Struct Biol,
12,
503-508.
|
 |
|
|
|
|
 |
P.Rezacova,
J.Brynda,
M.Fabry,
M.Horejsi,
R.Stouracova,
J.Lescar,
V.Chitarra,
M.M.Riottot,
J.Sedlacek,
and
G.A.Bentley
(2002).
Inhibition of HIV protease by monoclonal antibodies.
|
| |
J Mol Recognit,
15,
272-276.
|
 |
|
|
|
|
 |
A.P.Campbell,
W.Y.Wong,
R.T.Irvin,
and
B.D.Sykes
(2000).
Interaction of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pili strain PAK with a cross-reactive antibody: conformation of the bound peptide.
|
| |
Biochemistry,
39,
14847-14864.
|
 |
|
|
|
|
 |
C.A.Sotriffer,
B.M.Rode,
J.M.Varga,
and
K.R.Liedl
(2000).
Elbow flexibility and ligand-induced domain rearrangements in antibody Fab NC6.8: large effects of a small hapten.
|
| |
Biophys J,
79,
614-628.
|
 |
|
|
|
|
 |
E.Thouvenin,
and
E.Hewat
(2000).
When two into one won't go: fitting in the presence of steric hindrance and partial occupancy.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
1350-1357.
|
 |
|
|
|
|
 |
E.S.Calderon-Aranda,
B.Selisko,
E.J.York,
G.B.Gurrola,
J.M.Stewart,
and
L.D.Possani
(1999).
Mapping of an epitope recognized by a neutralizing monoclonal antibody specific to toxin Cn2 from the scorpion Centruroides noxius, using discontinuous synthetic peptides.
|
| |
Eur J Biochem,
264,
746-755.
|
 |
|
|
|
|
 |
J.L.Pellequer,
S.Chen,
V.A.Roberts,
J.A.Tainer,
and
E.D.Getzoff
(1999).
Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
|
| |
J Mol Recognit,
12,
267-275.
|
 |
|
|
|
|
 |
J.van den Elsen,
L.Vandeputte-Rutten,
J.Kroon,
and
P.Gros
(1999).
Bactericidal antibody recognition of meningococcal PorA by induced fit. Comparison of liganded and unliganded Fab structures.
|
| |
J Biol Chem,
274,
1495-1501.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Choulier,
N.Rauffer-Bruyère,
M.Ben Khalifa,
F.Martin,
T.Vernet,
and
D.Altschuh
(1999).
Kinetic analysis of the effect on Fab binding of identical substitutions in a peptide and its parent protein.
|
| |
Biochemistry,
38,
3530-3537.
|
 |
|
|
|
|
 |
N.Verdaguer,
T.C.Marlovits,
J.Bravo,
D.I.Stuart,
D.Blaas,
and
I.Fita
(1999).
Crystallization and preliminary X-ray analysis of human rhinovirus serotype 2 (HRV2).
|
| |
Acta Crystallogr D Biol Crystallogr,
55,
1459-1461.
|
 |
|
|
|
|
 |
T.Kieber-Emmons,
C.Lin,
M.H.Foster,
and
T.R.Kleyman
(1999).
Antiidiotypic antibody recognizes an amiloride binding domain within the alpha subunit of the epithelial Na+ channel.
|
| |
J Biol Chem,
274,
9648-9655.
|
 |
|
|
|
|
 |
A.Rodríguez-Romero,
O.Almog,
M.Tordova,
Z.Randhawa,
and
G.L.Gilliland
(1998).
Primary and tertiary structures of the Fab fragment of a monoclonal anti-E-selectin 7A9 antibody that inhibits neutrophil attachment to endothelial cells.
|
| |
J Biol Chem,
273,
11770-11775.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.A.Hewat,
T.C.Marlovits,
and
D.Blaas
(1998).
Structure of a neutralizing antibody bound monovalently to human rhinovirus 2.
|
| |
J Virol,
72,
4396-4402.
|
 |
|
|
|
|
 |
E.Y.Jones,
J.Tormo,
S.W.Reid,
and
D.I.Stuart
(1998).
Recognition surfaces of MHC class I.
|
| |
Immunol Rev,
163,
121-128.
|
 |
|
|
|
|
 |
M.A.Molins,
M.A.Contreras,
I.Fita,
and
M.Pons
(1998).
Solution conformation of an immunogenic peptide from HRV2: comparison with the conformation found in a complex with a Fab fragment of an anti-HRV2 neutralizing antibody.
|
| |
J Pept Sci,
4,
101-110.
|
 |
|
|
|
|
 |
P.Rondard,
and
H.Bedouelle
(1998).
A mutational approach shows similar mechanisms of recognition for the isolated and integrated versions of a protein epitope.
|
| |
J Biol Chem,
273,
34753-34759.
|
 |
|
|
|
|
 |
X.Barril,
C.Alemán,
M.Orozco,
and
F.J.Luque
(1998).
Salt bridge interactions: stability of the ionic and neutral complexes in the gas phase, in solution, and in proteins.
|
| |
Proteins,
32,
67-79.
|
 |
|
|
|
|
 |
A.P.Campbell,
D.L.Bautista,
B.Tripet,
W.Y.Wong,
R.T.Irvin,
R.S.Hodges,
and
B.D.Sykes
(1997).
Solution secondary structure of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pili strain PAK: A heteronuclear multidimensional NMR study.
|
| |
Biochemistry,
36,
12791-12801.
|
 |
|
|
|
|
 |
E.A.Hewat,
N.Verdaguer,
I.Fita,
W.Blakemore,
S.Brookes,
A.King,
J.Newman,
E.Domingo,
M.G.Mateu,
and
D.I.Stuart
(1997).
Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.
|
| |
EMBO J,
16,
1492-1500.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Keitel,
A.Kramer,
H.Wessner,
C.Scholz,
J.Schneider-Mergener,
and
W.Höhne
(1997).
Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity.
|
| |
Cell,
91,
811-820.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.A.Hewat,
and
D.Blaas
(1996).
Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.
|
| |
EMBO J,
15,
1515-1523.
|
 |
|
|
|
|
 |
K.U.Knowlton,
E.S.Jeon,
N.Berkley,
R.Wessely,
and
S.Huber
(1996).
A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
|
| |
J Virol,
70,
7811-7818.
|
 |
|
|
|
|
 |
L.Liljas
(1996).
Viruses.
|
| |
Curr Opin Struct Biol,
6,
151-156.
|
 |
|
|
|
|
 |
P.Orlewski,
M.Marraud,
M.T.Cung,
V.Tsikaris,
M.Sakarellos-Daitsiotis,
C.Sakarellos,
E.Vatzaki,
and
S.J.Tzartos
(1996).
Compared structures of the free nicotinic acetylcholine receptor main immunogenic region (MIR) decapeptide and the antibody-bound [A76]MIR analogue: a molecular dynamics simulation from two-dimensional NMR data.
|
| |
Biopolymers,
40,
419-432.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.R.Neurath,
N.Strick,
and
A.K.Debnath
(1995).
Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
|
| |
J Mol Recognit,
8,
345-357.
|
 |
|
|
|
|
 |
G.Siligardi,
and
A.F.Drake
(1995).
The importance of extended conformations and, in particular, the PII conformation for the molecular recognition of peptides.
|
| |
Biopolymers,
37,
281-292.
|
 |
|
|
|
|
 |
J.Tormo,
N.B.Centeno,
E.Fontana,
T.Bubendorfer,
I.Fita,
and
D.Blaas
(1995).
Docking of a human rhinovirus neutralizing antibody onto the viral capsid.
|
| |
Proteins,
23,
491-501.
|
 |
|
|
|
|
 |
N.Verdaguer,
M.G.Mateu,
D.Andreu,
E.Giralt,
E.Domingo,
and
I.Fita
(1995).
Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction.
|
| |
EMBO J,
14,
1690-1696.
|
 |
|
|
|
|
 |
R.L.Stanfield,
and
I.A.Wilson
(1995).
Protein-peptide interactions.
|
| |
Curr Opin Struct Biol,
5,
103-113.
|
 |
|
|
|
|
 |
I.A.Wilson,
and
R.L.Stanfield
(1994).
Antibody-antigen interactions: new structures and new conformational changes.
|
| |
Curr Opin Struct Biol,
4,
857-867.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|